Biostar Pharmaceuticals Inc (BSPM)

Biostar Pharmaceuticals Inc is a common stock listing on OTC Markets for a healthcare company focused on pharmaceuticals. The company develops, manufactures, and markets medicines for a range of diseases and conditions in the People’s Republic of China. Its product portfolio includes both over-the-counter and prescription pharmaceutical products. Key OTC products mentioned in the source include Xin Ao Xing Oleanolic Acid capsules for chronic hepatitis B, as well as treatments used for symptoms related to colds, menstrual pain, chronic gastritis, joint pain, and cataracts. The company also sells prescription products such as Danshen granules, Piracetam tablets, Fosfomycin Calcium capsules, and Aspirin Enteric-coated tablets. Biostar Pharmaceuticals distributes its products through distributors and via an internet-based hospital platform that provides hepatitis B information and treatment-related purchasing access. The company was incorporated in 2007 and is headquartered in Xianyang, China.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Market Cap
OTC-BSPM
Not available
Not available
Not available
Good
0.0%
0.263 K
Valuation • Fair Value

Biostar Pharmaceuticals Inc (OTC-BSPM) Fair Value by Valuation Model

No usable valuation estimate is currently available for Biostar Pharmaceuticals Inc (OTC-BSPM); fair value and analyst target coverage statuses are shown explicitly below.

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

No usable valuation estimate is currently available for Biostar Pharmaceuticals Inc (OTC-BSPM). Fair value and the analyst target remain visible as coverage-status fields and should not be read as valuation signals while unavailable.

Profitability • Growth

Profitability & Growth for Biostar Pharmaceuticals Inc (OTC-BSPM)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Biostar Pharmaceuticals Inc (OTC-BSPM) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Biostar Pharmaceuticals Inc (OTC-BSPM)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Biostar Pharmaceuticals Inc (OTC-BSPM). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Dividend Profile for Biostar Pharmaceuticals Inc (OTC-BSPM)

Review the dividend metrics currently supported by the latest data.

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

The latest data indicates no current dividend yield for Biostar Pharmaceuticals Inc (OTC-BSPM). No upcoming dividend amount or event date is currently available.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Biostar Pharmaceuticals Inc (OTC-BSPM) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Biostar Pharmaceuticals Inc (OTC-BSPM) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Sell

The daily technical read for Biostar Pharmaceuticals Inc (OTC-BSPM) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Sell

The weekly technical read for Biostar Pharmaceuticals Inc (OTC-BSPM) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Biostar Pharmaceuticals Inc (OTC-BSPM) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ Fast Investor Answers

Biostar Pharmaceuticals Inc (OTC-BSPM) Stock FAQ

Data-supported answers about Biostar Pharmaceuticals Inc (OTC-BSPM), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Financial Health
Good
Current financial-health read

A reliable fair value estimate is not currently available for Biostar Pharmaceuticals Inc (OTC-BSPM). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The current financial health read for Biostar Pharmaceuticals Inc (OTC-BSPM) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The latest available data indicates no current dividend yield for Biostar Pharmaceuticals Inc (OTC-BSPM).

The current market capitalization listed for Biostar Pharmaceuticals Inc is 0.263 K.

The ticker symbol for Biostar Pharmaceuticals Inc is OTC-BSPM, and the stock is listed on OTC Markets.

Biostar Pharmaceuticals Inc (OTC-BSPM) is listed on OTC Markets.